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Since its definition in 1932, it has been recognized that 
Crohn’s disease contains elements that might be the 
result of microbial processes in the gut [I-41. These 
include evidence of onset in the Peyer’s patches and in 
lymphoid aggregates of the colon, ulcerations, micro- 
abscesses, fissures, fistulas, granulomas and lymphan- 
gitis. Aphthous ulcers in the intestine represent the 
earliest lesions, and we know that these occur in viral 
and bacterial infections. Crohn’s lesions occur in 
segments that suggest the distribution of Peyer’s 
patches. Ulcerations in colonic Crohn’s disease origin- 
ate in the follicle-associated epithelium of colonic 
lymphoid nodules. 
Recent studies in animal models have led to the 
widespread belief that microbial constituents provide 
the antigenic stimulus in Crohn’s disease, and the most 
common hypothesis is that chronic inflammation 
results from an abnormal host immune response to 
normal luminal flora. Although present data do not 
convincingly incriminate a single, persistent pathogen 
as a universal cause of Crohn’s disease, this hypothesis 
should not be abandoned. Our current understanding 
of the complexity of the intestinal flora is very limited, 
and it is quite possible that one or more etiologic agents 
for Crohn’s disease exist but have not been detected. 
We will review in this note the infectious agents which 
have been implicated in the etiology of Crohn’s disease 
within the last few years. 
Mycobacteria 
The etiologic role of mycobacteria in Crohn’s disease 
has been a controversial issue for some time. In 1984, 
Chiodini et al recovered slow-growing Mycobacteriurn 
paratuberculosis from tissues of three patients with 
Crohn’s disease 151, and it was encouraging that other 
laboratories also recovered this organism, albeit rarely. 
However, 15 years later, data subsequently obtained do 
not strongly support this hypothesis. Six separate 
immunocytochemistry studies on varied groups of 
patients have failed to find M.  paratuberculosis in diseased 
tissues, and numerous serologic studies have failed to 
document elevated titers or changes in titer in relation 
to disease activity. With the exception of a paper by 
Prantera et al [6] ,  controlled trials with antibiotics 
directed against mycobacteria have failed to make 
patients well, and the clinical improvement of Prantera’s 
patients may reflect a broad-spectrum antibiotic effect 
on secondary invaders. A recent 5-year follow-up study 
of patients receiving rifampicin, isoniazid, and 
ethambutol for up to 2 years failed to show any benefit 
in treated patients [7] .  Dairy cattle with Johne’s disease 
shed great numbers of M. paratuberculosis into the 
environment, and it has been reported that M.  
paratuberculosis strains isolated from patients with 
Crohn’s disease had a common clonal origin with 
strains isolated from cows with Johne’s disease. 
However, there has never been any recorded case of 
Crohn’s disease occurring in farm staff or farmer’s 
families associated with these herds. Studies involving 
the use of PCR techniques to amplify the IS900 
insertion sequence, specific for M.  paratuberculosis, in 
intestinal biopsies have given controversial results. 
At the present time, the remote possibility 
remains that only a specifically susceptible subset of 
Crohn’s disease patients might have a mycobacterial 
etiology. 
Vasculitis and the measles virus 
A more recent thrust at discovery has been the work of 
Wakefield et al, first put forward 8 years ago, when it 
was proposed that microvascular occlusion constitutes 
the earliest lesion and basis of Crohn’s disease [8]. A 
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further step in the work from this group was the 
proposal that Crohn’s disease may be a persistent 
measles virus-induced granulomatous vasculitis. Measles 
virus antigen and mRNA were locahzed to granulomas 
and endothelial cells by in situ hybridzation, immuno- 
fluorescence and immunogold electron microscopy [8] ,  
and antimeasles antibody was reported to be elevated. 
Epidemiologic arguments supported the hypothesis. 
Early exposure to measles virus, live-attenuated measles 
vaccination and prenatal exposure to measles were all 
associated with an increased risk [9]. However, the 
interpretation of studes implicating measles virus has 
been challenged. Over the past several years it has been 
shown that mesenteric blood vessels are not primary 
sites of Crohn’s disease. Furthermore, the presence of 
measles virus in the tissues has not been confirmed by 
independent investigators [lo], and measles viral 
genomic sequences could not be detected in intestinal 
tissue from Crohn’s patients by PCR [ll] .  As for 
serologic studies, we saw no titers that would have 
suggested measles virus participation in families with a 
high frequency of Crohn’s disease [12]. Finally, recent 
epidemiologic studies failed to confirm the original 
association [13]. Thus the theory of measles as a 
causative factor in the development of Crohn’s disease 
is dfficult to uphold. 
Listeria 
There has been renewed interest in the transmittable 
agent hypothesis after the report of Crohn’s disease 
occurring in multiple siblings of two French families 
within a short time period [14]. When a polyclonal 
antibody against Listeria monocytogenes was applied to 
the tissues of patients, including those of these f a d e s ,  
antigen was demonstrated in 75% and not in controls 
[lo]. However, there are several data elements that 
militate against the hypothesis that Listeria is important 
in Crohn’s disease: Listeria has never been cultivated 
from Crohn’s intestinal tissue, and a recent PCR study 
has given negative results [15]. Finally, there is no 
association in the literature between the occurrence of 
Crohn’s disease and Listeria meningoencephalitis or 
abortion. 
Helicobacter hepaticus 
Since the discovery of H. pylori, interest in other 
Helicobacter species has increased. H. hepaticus is a 
murine pathogen which can induce colitis and hepatitis 
in immunodeficient mice and in germ-free mono- 
infected mice. Scid mice reconstituted with CD4’ T- 
cells develop severe colitis when maintained in conven- 
tional conditions. In this model, the combination of H. 
hepaticur infection and CD45Rshigh CD4’ T-cell 
reconstitution resulted in severe disease expression [16]. 
A group of Helicobacter species has also been identified 
from the lower gastrointestinal tract of humans and, in 
the case of two species, H. cinaedi and H. fenelliae, 
human infection has been associated with colitis and 
proctitis in homosexual men. H. hepaticus does not 
appear to be involved in chronic intestinal inflam- 
mation in mice with functioning T-lymphocytes. 
Furthermore, no Helicobacter species has been isolated 
so far from feces or mucosal samples of patients with 
Crohn‘s disease. 
Yeasts 
Systemic antibodies to various dietary and bacterial 
antigens have been reported in sera from patients 
with Crohn’s disease and ulcerative colitis. Using 
ELISA, which employs whole killed yeast cells as 
antigens, elevated anti-Saaharomyces cereuisiae antibody 
(ASCA) levels were reported in the sera from Crohn’s 
patients and not from patients with ulcerative colitis. In 
1996, we showed that this serologic response recognizes 
mannose sequences in the cell wall mannan of 
S. cerevisiae strain Sul (formerly S. warurn 1, a species 
now classified within S. cereuisiae) [17]. ASCAs 
constitute a specific marker for Crohn’s dsease and are 
present in 20% of healthy relatives of patients, 
suggesting that they could represent a subclinical 
marker [18,19]. Different hypotheses concerning the 
origin of ASCAs can be proposed [17]. The first one 
to consider is that they may originate from immuniz- 
ation by yeasts. A second hypothesis worth testing is 
that yeast mannan oligomannosides could correspond 
to epitopes shared by other microorganisms. Finally, the 
ubiquitous character of mannose residue sequences 
raises a thrd hypothesis: some S. cereuisiae oligoman- 
nosides might share structural homologies with 
oligomannosides expressed on human glycoconjugates 
as autoantigens or neo-autoantigens. 
Endogenous bacteria 
Abundant experimental and clinical data incriminate 
normal luminal bacteria or bacterial products in the 
initiation and perpetuation of chronic intestinal 
inflammation 11-41. The most convincing evidence of 
the potential role for bacteria comes from genetically 
engineered rodent models that develop intestinal 
inflammation. In these models, inflammation is absent 
or attenuated when animals are kept under germ-free 
conditions [20,21]. In humans, there is evidence that 
bacteria might be involved, at least as secondary 
invaders, in the pathogenesis of Crohn’s disease [3,4]. 
Bacterial flora might also play a primary role. 
Endoscopic studies after surgery have suggested that 
bacteria are important in recurrence: diverting 
ileostomy prevents postoperative recurrence, which 
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rapidly occurs afier reanastomosis [22] .  This suggests 
that the fecal stream (and most likely bacteria) triggers 
the onset of early new ileal lesions of Crohn’s disease. 
We have also shown that, in this situation, the 
neoterminal ileum above the ileocolonic anastomosis is 
heavily colonized by a colonic-like bacterial flora, with 
prominent bacteria being Bacteroides, Clostriditrm and 
Eschericliia coli. 
All bacterial species may not have equal activity in 
inducing inflammation. Defined flora studies showed 
that Bacteroides spp. preferentially induce colitis in HLA 
B27 transgenic rats [23]. Among the numerous bacteria 
of the intestinal flora, E. coli has also been thought to 
be involved. E. coli antibody titers are higher in Crohn’s 
patients than in controls. When bacteriologic sampling 
was undertaken at surgery for Crohn’s disease, before 
bowel opening, E. coli was recovered from 33% of 
mesenteric lymph nodes versus 5% in controls [24]. 
E. coli antigen was observed by immunostaining in 
69% of diseased intestinal resection specimens versus 
27% in controls [25]. A correlation has been shown 
between high numbers of E. coli and the presence and 
severity of inflammatory bowel disease in HLA-B27 
rats [26]. 
We recently characterized several E. coli isolates 
that were recovered from ileal mucosa of patients with 
Crohn’s disease [27]. Our findings indicate that E. coli 
strains associated with ileal mucosa of such patients 
adhere preferentially to differentiated Caco-2 cells, 
corresponding to mature intestinal cells. The identifi- 
cation of the adhesins involved was performed by P C R  
and hybridization assays. Of the 30 patient strains that 
adhered to differentiated intestinal cells, 73% harbored 
an adhesin that was not identified by the use of 
molecular technniques using the different DNA probes 
or primers specific to the structural genes encoding 
known adhesins of diarrheagenic E. coli or E. coli 
involved in human urinary tract infections. None of the 
E. coli strains isolated from biopsies of patients with 
Crohn’s disease possess any of the virulence genes 
harbored by pathogenic E.  coli strains. A cytotoxic 
effect on cultured intestinal cells was observed after a 
3-h infection. DNA hybridization experiments with 
the various probes corresponding to known cytotoxin- 
encoding genes were positive with the a-hemolysin 
probe for 21.8% of the strains. Such a percentage was 
much higher than those observed in diarrheal stools 
(5.3%) or controls (2.2%) [28]. The E. coli a-hemolysin 
is a potent stimulus for the release of inflammatory 
mediators like 02-,  0-glucuronidase, leukotriene and 
histamine. The combination of adhesive ability and 
synthesis of a cytotoxin might allow the bacteria to 
colonize intestinal epithelium, damage intestinal cells 
and participate in the inflammatory disease. 
Conciusion 
The etiopathogenesis of Crohn’s disease remains 
unknown, although an enormous amount of data has 
appeared in recent years. Environmental and genetic 
contributions are evident. Microbial agents appear to 
be intimately involved in the pathogenesis, but no 
causative microorganism has been found. Chronic 
intestinal and systemic inflammation requires the inter- 
action of both genetic and bacterial factors, but neither 
alone is sufficient to induce chronic colitis or enteritis. 
Finally, resolution of the enigma may be hampered 
owing to disease heterogeneity, and the possibility exists 
that Crohn’s disease might represent a syndrome with 
multiple etiologies. 
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